Inovio and MVI partner to develop malaria vaccines using innovative vaccine delivery technology

February 1, 2013
Ankur Sohanpal

Inovio Pharmaceuticals, in collaboration with MVI, or the PATH Malaria Vaccine Initiative, will develop new malarial vaccines and also test innovative delivery mechanisms. Read more here.



View Our Publications

Case Studies, Learnings and More!

View Publications


Footer Image

Get In Touch